Navigation Links
A 'Must Read' for Breast Cancer Patients
Date:12/18/2007

SAN JOSE, Calif., Dec. 18 /PRNewswire/ -- Patent 7,309,486 issued on 12/18/07 to NexGen Biomedical, Inc. founder Mark Zamoyski of San Jose, California discloses a better way of using Genentech's drug Herceptin(R) against breast cancer. The patent discloses that today's practice of concurrent administration of Herceptin(R) with conventional phase specific chemotherapy results in antagonistic action between the two classes of drugs. In later stage cancers, these protocols only increase median survival by several months.

Patent 7,309,486 discloses novel protocols that allow the two classes of chemotherapeutics to function synergistically. The protocols are designed to provide a way of holding the cancer in check indefinitely.

All proliferating cells progress through 4 distinct phases termed G1, S, G2, and M. "S-Phase cytotoxics, such as Pfizer's Camptosar(R) or Eli Lilly's Gemzar(R), are capable of killing virtually all cells that are in the S-Phase, however, in the best case, only around one third of cancer cells are typically in the S-Phase during chemotherapy," explains Mark Zamoyski, the inventor. "The patented protocols boost the number of cells in the S-Phase by exploiting the cancer's unique mutation profile to establish a "road block" to aggregate a large number of cancer cells at a point prior to the S-Phase, the road block is then removed to allow the wave of cancer cells to enter the S-Phase during the administration time of the S-Phase cytotoxic chemotherapy, and then the road block is reestablished to start aggregating surviving cancer cells for the next administration of S-Phase cytotoxic chemotherapy."

The abstract contained in the patent has been incorrectly truncated and a correct synopsis of the patent is available at http://www.nexgen.biz under Cell Cycle Synchronous Chemotherapy.


'/>"/>
SOURCE NexGen Biomedical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Middle East Pharma Manufacturing/Biotech is Ready to Boom
2. Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center
3. Significant Progress Made in Nations Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
6. Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia
7. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
8. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
9. Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
10. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
11. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... American Filtration and Separations Society will hold its 23rd Annual Technical ... Hotel in San Antonio, Texas. To further impact the separation society ... are proud to announce that the 2010 AFS Annual Technical Conference ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- ...
(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...
(Date:12/15/2009)... Force Microscopy (AFM) have been developed and are opening up ... interface. The NeedleProbes’ cylindrical geometry enables researchers to measure ... - all in a single force distance curve. , ... ... constant diameter NeedleProbes are enabling unique measurements at ...
(Date:12/15/2009)... 15 On January 20th, 2010, the ... Medical Publication Professionals (ISMPP) will be held at ... More than 100 attendees are expected at this ... professionals, editors, publishers, medical writers and medical agencies ... and the impact of guidelines and regulations such ...
Breaking Biology Technology:American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2
... proof-of-concept for diagnosing Parkinson,s ... Foundation awards grant to Molecular Biometrics for further ... development of Parkinson,s diagnostic, CHESTER, ... June issue of the peer-reviewed journal, Biomarkers in Medicine,demonstrated proof-of-concept ...
... BNVI ) today announced results for the second ... did not report any revenue for the three and ... $7,500 for the three and six,months ended June 30, ... with a Taiwanese company. In October of 2007,we terminated ...
... 5 NeoStem, Inc. (Amex: NBS ),announced today that ... Gables, a suburb of Miami, is targeted to open in,September. ... CelVida,LLC. With the opening of this center, NeoStem has secured ... a large U.S. market as well as a,growing sophisticated South ...
Other Biology Technology:Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 2Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 3Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 4Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 5Bionovo Reports Second Quarter 2008 Financial Results 2Bionovo Reports Second Quarter 2008 Financial Results 3Bionovo Reports Second Quarter 2008 Financial Results 4Bionovo Reports Second Quarter 2008 Financial Results 5Bionovo Reports Second Quarter 2008 Financial Results 6Bionovo Reports Second Quarter 2008 Financial Results 7NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide 2NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide 3
(Date:12/15/2009)... GenWay Clinical Laboratory, San Diego, California, has been ... Pathologists (CAP), based on results of a recent ... was advised of this national recognition and congratulated ... GenWay Biotech Inc. GenWay Clinical Laboratory is one ... CAP Laboratory Accreditation Program, begun in the early ...
(Date:12/15/2009)... 2006, a team of Spanish and American researchers found the ... Bonares, Huelva. Now they have published, for the first time, ... with the death of the young cetacean, possibly a baleen ... first discovery of the partial fossil remains of a whale ... Huelva Sands sedimentary formation, but it is the first time ...
(Date:12/15/2009)... a standard laboratory model organism, but there are ... analyze blood and blood-forming tissues in this species. ... easy-to-use laboratory resources from Cold Spring Harbor Laboratory ... features step-by-step protocols for the preparation, enumeration, ... and other hematopoietic tissues in the mouse. ...
Breaking Biology News(10 mins):Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3New source of classical techniques for blood-based studies in the laboratory mouse 2Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 1Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 2Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 3Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 1Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 2Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 1Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 2
... randomized clinical trial for patients with previously untreated ... spread from the breast to other parts of ... bevacizumab (Avastin? in combination with standard chemotherapy had ... than patients who received the same chemotherapy without ...
... Institute for OneWorld Health, the first nonprofit pharmaceutical company ... Drug Designation from the two leading regulatory agencies in ... the European Agency for the Evaluation of Medicinal Products ... VL, also known as kala azar ("black fever"), is ...
... in the ecological community to agree a set of ... being led by the British Ecological Society's Journal of ... profile on river restoration. Opening the debate is a ... criteria for ecologically successful river restoration. Their aim is ...
Other Biology News:Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 2Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 3OneWorld Health drug receives 'Orphan' designation from U.S. and European regulatory agencies 2Putting ecology back into river restoration 2
... The S.c. EasyComp Transformation Kit ... transformation-competent Saccharomyces cerevisiae cells. Advantages over ... spheroplast formation or LiCl methods include:- Cells ... than 30 minutes - Competent cell preparation ...
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... of BAC (100+kb), fosmid (40kb), and large ... than any othe BAC vector. On command ... and easy recombinant DNA purification. Available with ... VC) vectors for the highest insert stability. ...
... (100+kb), fosmid (40kb), and large plasmid insert ... othe BAC vector. On command 20-50 fold ... recombinant DNA purification. Available with blue-white screening ... for the highest insert stability. Kits include ...
Biology Products: